This is the authors' abstract. We don't add key points for this paper.
In humans, inhaled manganese (Mn) initiates neurodegeneration in the striatum and produces manganism, a disorder phenotypically mimetic of Parkinson's disease (PD), and it is unclear how Mn has this effect. The main route of inhaled Mn passage to striatum – via direct transneuronal transport via the olfactory system or indirectly via lungs to blood, and the relative contributions of each of these pathways – also remain unclear. The primary goal of this investigation was to explore these questions – and others – quantitatively in a rat model. An 11-compartment whole-body physiologically-based toxicokinetic (PBTK) model of Mn distribution, optimally and simultaneously fitted to a single set of multiorgan rat data was used. The fully quantified model provided numerous kinetic parameters, including the relative distribution of whole-body Mn for each compartment in response to a constant simulated input of inhaled Mn, and the relative contributions of olfactory and pulmonary pathways. The liver, which actively concentrates Mn, was found to contain the greatest percentage (∼6.7%). Both the striatum and cerebellum had (∼0.1%) of total Mn, which is notable given that striatum volume is approximately 100-fold less than cerebellum. The relative percentages of olfactory (∼52%) and pulmonary (∼48%) contributions to Mn in striatum were approximately constant computed for up to 200 days after aerosolized exposure. Following simulated acute exposure (>1 mg Mn/m3), clearance from striatum was nearly complete after ∼100 days. In a separate simulation of low-level chronic exposure (∼0.01 mg Mn/m3), striatal Mn was saturated and reached an approximately steady value at 100 days.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Douglas et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: